Texas Biomed will test mAb 77 in juvenile rhesus monkeys next month — a possible first antiviral for measles as cases rise. The study builds on a 2024 Science discovery.

A 20i survey finds Texas web designers report more pay satisfaction than peers on the coasts, even with lower average salaries. Cost of living and career stage appear to matter more than raw dollars.

A San Antonio firm demonstrated a prototype lunar excavator and partnered with Astrolab to outfit FLEX rovers with interchangeable tools for landing pads, roads and reactor sites on the Moon.

An investigation ties contaminated medicines, falsified testing and inspection gaps to overseas factories — and patients are already paying the price.

Mayor Gina Ortiz Jones tapped a new 11‑member advisory group — led by Port San Antonio’s CEO — to pitch AI, biotech and space manufacturing to the city. The panel will advise on projects and may feed into future bond planning.

Federal grants and DoD partnerships have pushed Texas A&M‑San Antonio into a growing cybersecurity hub, with ABET accreditation and tangible student placements.

A Texas State/X‑Bow plan to static‑test solid rocket motors at Freeman Ranch has neighbors and conservationists warning the Edwards Aquifer could be at risk. University officials say safeguards are planned.

UTSA researchers and maintainers warn AI-generated code is hallucinating package names, creating a predictable new supply-chain attack dubbed “slopsquatting.”

A San Antonio nonprofit launched a bus-sized leukapheresis unit to collect immune cells for cell therapies, aiming to cut travel burdens for South Texas patients.

Austin approved a jobs‑based incentive for South Korea’s 3billion to open a 12,994‑sq‑ft genetic testing lab, promising about 200 jobs and capacity for 50,000 tests a year.

ERCOT's new 'batch' interconnection plan could put about 8.2 GW of approved data‑center load back under review, forcing clearer timelines and staged commitments.

Texas Governor Abbott expands the ban on state use of certain technologies to protect against espionage and data theft, particularly from China-related entities, in collaboration with the TXCC.

UH researchers found that swapping the drug on an antibody‑drug conjugate restored tumor control in preclinical breast‑cancer models. The results were presented at SABCS.